
The study demonstrates that ultra-short, fine-gauge needles—such as the STERiJECT 32G x 4mm needle—enable highly effective injections with significantly reduced pain, improved control, and consistent delivery performance. These needles achieved favorable patient-reported outcomes, supporting their suitability for precise, low-trauma procedures while maintaining clinical efficacy comparable to conventional alternatives.
Study FindingsAcross comparative evaluations, STERiJECT 32G x 4mm needles showed equal or superior performance versus thinner or longer alternatives in terms of pain perception and injection force. Participants consistently reported less discomfort and easier dose delivery, indicating that further reductions in gauge or length do not necessarily improve outcomes beyond this optimized design.
Clinical ImplicationsThe findings highlight that needle design—beyond just size—plays a critical role in injection performance. Innovations such as optimized hub geometry and ultra-thin wall construction improve flow, reduce required force, and enhance user experience. As a result, well-engineered STERiJECT 32G x 4mm needles represent a balanced solution for safe, precise, and patient-friendly injections across clinical applications.
Source:
Journal of Clinical Aesthetic Dermatology. 2020; Evaluation of 32G 4 mm Needles for Injection Performance and Patient Comfort. DOI: 10.3928/23258160-20200702-05.
Whether you are a healthcare professional, pharmaceutical partner, distributor, or researcher, we invite you to explore how ACollaboratory can support your goals.